The American Society of Hematology Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2019
NCT03948867
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

American Society of Hematology | The American Society of Hematology